BYLVAY® (odevixibat)

BYLVAY® (odevixibat) is indicated for the treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC) or for the treatment of cholestatic pruritus in patients 12 months of age and older with Alagille syndrome (ALGS)